Abstract A full-length cDNA encoding a novel protein was isolated and sequenced from a human placental cDNA library. This cDNA consists of 1735 base pairs and has a predicted open reading frame (ORF) encoding 354 amino acids. It possesses a putative signal sequence, a long extracellular domain, a transmembrane region, a short intracellular domain, and no catalytic domain, which is highly homologous to signal-regulatory protein (SIRP)-, suggesting that it seems to be a new member of the SIRP family. Polymerase chain reaction (PCR)-based mapping with both a monochromosomal hybrid panel and radiation hybrid cell panels placed the gene to human chromosome 20p13 near the marker D20S906.
Introduction
Signal-regulatory proteins (SIRPs) comprise several cellsurface glycoproteins (Kharitonenkov et al. 1997) . These molecules are structurally characterized by an extracellular Ig superfamily domain, a transmembrane domain, and an intracellular domain, and are likely to play a significant role in neurons, fibrocytes, and myeloid cells (Fujioka et al. 1996; Kim et al. 1998; Sano et al. 1997; Saginario et al. 1998; Machida et al. 2000) . In higher eukaryotes, SIRPs are present as a large group of proteins (Kharitonenkov et al. 1997) . However, the physiological role of all of these proteins is not yet clear. The identification and characterization of a variety of proteins in the family are necessary to elucidate the precise mechanisms of the family's cellular function. In this article we describe the cloning and characterization of a novel human gene that encodes a protein presumably belonging to the SIRP family. We named the molecule SIRP-B2, as it seemed to be a new molecule most similar to SIRP-.
Methods, results, and discussion
Rhambda libraries of cDNA were screened by lowstringency hybridization (Kuramochi et al. 1996; Matsuda et al. 1996) , using a DNA fragment corresponding to the Src homology 2 containing protein tyrosine phosphatase 2 substrate 1 (SHPS-1) coding domain (amino acid 154-481) as a probe to yield cDNAs encoding full-length clones. One of the libraries used had been produced from poly (A)ϩRNA isolated from placenta (Clontech, Palo Alto, CA, USA) to get positive clones. DNA sequencing was then performed, using a Sequenase Kit (Amersham, Cleveland, OH, USA) and automatic sequencers for dideoxy sequencing (Amersham, Cleveland, OH, USA) according to the supplier's instructions. The resultant consensus sequence was employed as the correct cDNA sequence. A coding sequence of the positive clone was found to have some homology to the SHPS-1 domain, but was a new gene, suggesting that it represented a potential novel protein belonging to the SIRP/SHPS-1 protein family, as expected. The determined nucleotide sequence and predicted amino acid sequence are shown in Fig. 1A . The cDNA of 1735 bp contains an open reading frame of 1062 bp. The SIRP-B2 protein was then predicted to consist of 354 amino acids. There is a potential ATG start codon favored (Kozak 1989) from position 181 (Fig. 1A) . As illustrated schematically in Fig. 1 , the predicted SIRP-B2 protein contains a putative signal sequence, a long extracellular domain, a transmembrane region, a short intracellular domain, and no catalytic domain, which is highly homologous to SIRP family members.
A search of the protein database (SWALL and PIR) revealed that SIRP-B2 had high homology to several other proteins. The amino acid sequence of SIRP-B2 was most homologous to that of SIRP-(75.5% identical). The amino acid sequences in the protein were compared (Fig. 1C) . However, preliminary analysis indicated that the SIRP-B2 was not a result of alternative splicing (data not shown) (Sano et al. 1999) . The deduced amino acid sequence contains a putative transmembrane region that separates an extracellular domain from a cytoplasmic domain that does not include a potential tyrosine-phosphorylation site capable of recruiting some signaling molecules, although SHPS-1 has this site (Veillette et al. 1998) . Based on the structural features of SIRP-B2, we propose that SIRP-B2 may also serve as a signal-regulatory receptor for mediating a certain signal transduction. In order to understand the biological functions of SIRP-B2 in more detail, it is important to identify the proteins associated with SIRP-B2. Recently, it has been reported that SIRP-is associated with DAP12, which contains a single cytoplasmic immunoreceptor tyrosine-based activating motif (Dietrich et al. 2000) . We speculate that the isolation of these binding proteins to SIRP-B2 may reveal a novel signal transduction pathway.
The tissue distribution of SIRP-B2 transcript in various tissues was examined by using cycle-limited reverse transcription-coupled polymerase chain reaction (RT-PCR), as described previously (Ueki et al. 1999; Seki et al. 1999; Matsuda et al. 2000) . Primers used for RT-PCR correspond to the noncoding region of the gene (5Ј Ͼ AGCTTCTCT AGACTTG Ͻ 3Ј and 5Ј Ͼ CCATGAATGAAGACCT Ͻ 3Ј); the expected product corresponds to nt 1341 to 1456). Template-cDNAs from the human tissues were purchased from Clontech. As shown in Fig. 2A , SIRP-B2 mRNA expression was detected in brain, heart, lung, liver (most obvi- Asterisk shows the putative localization of the SIRP-B2 gene ous), pancreas, kidney, placenta, and in skeletal muscle by using cycle-limited RT-PCR (28 cycle-amplified), suggesting that SIRP-B2 may be ubiquitously expressed, although the levels of expression varied. In this experiment, genomic DNA may not have been amplified, because primers designed from intron DNA of SIRP-B2 could not be amplified (data not shown). Considering its expression profile, SIRP-B2 may be involved in a basic function of many cells, especially those in liver. To analyze the protein product of SIRP-B2, western analysis was performed. As shown in Fig.  2B , when a cDNA encoding the corresponding GFP-Myctagged SIRP-B2 protein was expressed in COS7 cells using pcDNA3.1 expression-plasmid (Invitrogen, Carlsbad, CA, USA), anti-tag (both anti-GFP and anti-Myc) antibodies (MBL) specifically detected a 65-kDa protein in the lysates of transfected COS7 cells ( Fig. 2B; lanes 3 and 4) . When a cDNA encoding the corresponding Myc-tagged SHPS-1 protein was expressed in COS7 cells, a correspondingly larger protein and some degradation protein were detected only by the anti-Myc antibody ( Fig. 2B; lane 1) for the positive control. The protein size detected in this experiment was as previously expected. These results showed that the gene of this SIRP-B2 surely had a coding potential, as expected.
To determine the chromosomal localization of the SIRP-B2 gene, PCR-based monochromosomal somatic cell hybrid mapping (Quantum, Montreal, Quebec, Canada) was performed with a set of 3Ј untranslated region (UTR) primers. This study indicated that the SIRP-B2 gene is located on human chromosome 20 (Fig. 3A) . To further refine the subchromosomal location of the gene, radiation hybrid (RH) panels (Stanford G3 and Genebridge 4) were utilized. Both of the linkage analyses of the PCR results (data vec- 4) and Myc-tagged SHPS-1 gene (lane 1) were reconstituted into pcDNA3.1-plasmid (Invitrogen) under the CMV promoter. These plasmids were then transfected into COS7 cells by lipofection (Lipofect ACE; GIBCO BRL, Grand Island, NY, USA). After 48 h of transfection, the protein in the lysates was fractionated by 10% sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with both anti-GFP (top panel) and anti-Myc (bottom panel) antibodies. Lane 2 (C) represents a non-transfected negative control tors for SIRP-B2 of the Stanford G3 and the Genebridge 4 RH panels: 10000 10000 00000 01010 10000 00100 00010 11000 00000 00000 10001 00001 00000 10000 00001 00000 010 and 10010 01001 01000 00010 10111 11111 01010 10001 11101 10100 00001 11000 00010 11000 01000 00100 00100 10000 001, respectively) showed that the SIRP-B2 gene was linked to several markers in the distal region of chromosome 20p13 near the marker D20S906, with lod score values higher than 10.8. The most likely order of the refined loci is shown in Fig. 3B . The SIRP-B2 gene is between SHGC-56794 and SHGC-21110, and is adjacent to the marker D20S906. It had been reported that the SHPS-1 gene is localized to chromosome 20p13 near SIRP-B2 (Yamao et al. 1997; Eckert et al. 1997) . Other genes that have been mapped to chromosome 20p13 include the M2-acute myeloblastic leukemia (AML) translocation (Xue et al. 1997 ) and acute promyelocytic leukemia (APL) translocation genes (Yamamoto et al. 1998) . Furthermore, the gene that, presumptively, causes Hallervorden-Spatz syndrome was also reported to be mapped to chromosome 20p12.3-13 (Taylor et al. 1996) . Our precise chromosomal positioning data should contribute toward positional candidate approaches for these disease genes linked to this locus. Future studies will address the biological role of SIRP-B2 in this regard.
